Viewing nowMecardis Tablet 80 mg (Telmisartan)
Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

MFDS item code 199907013 · Approved 1999.10.22 · Insurance code 653500350
Treatment of essential hypertension and prevention of cardiovascular disease in high-risk patients
This medicine is used for the treatment of essential hypertension. It also helps reduce the risk of myocardial infarction, stroke, and death from cardiovascular disease in patients aged 55 years and older who have a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attack or are at high risk of diabetes, particularly in those where ACE inhibitors cannot be used. In other words, it helps reduce the risk of cardiovascular disease and effectively manage hypertension.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine provides an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The effect of reducing the risk of cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medicine can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in individuals with hypersensitivity to this drug, pregnant or breastfeeding women, patients with severe liver impairment, individuals with a history of angioedema, and certain kidney and diabetes patients. Elderly patients, patients with hyperkalemia, liver disease, and those with heart and kidney disease should use this medicine cautiously, as there is a risk of significant drops in blood pressure. Various adverse reactions may occur while taking this medicine, and especially if symptoms such as hypotension, hyperkalemia, kidney dysfunction, or angioedema appear, immediate consultation with a healthcare provider is necessary. Patients with decreased kidney function should regularly check their serum potassium and creatinine levels, and patients with decreased blood volume may experience hypotensive symptoms; therefore, their status should be corrected before taking this medicine. The effect may be enhanced or adverse effects may increase when this medicine is taken with other antihypertensive agents, so healthcare providers should be informed about any concurrent medications. Caution is particularly needed when combined with lithium, non-steroidal anti-inflammatory drugs, and potassium-sparing diuretics; monitoring of serum levels may be recommended if necessary. This medicine should not be taken during pregnancy, and breastfeeding women should either avoid taking this medicine or stop breastfeeding. Safety and efficacy have not been established in children under 18 years of age, so it is not recommended for them. Elderly patients should be administered this medicine cautiously to avoid excessive blood pressure lowering, and they should be careful while driving or operating machinery due to the risk of dizziness or fainting. Overdose may cause hypotension, dizziness, acute kidney failure, etc., and immediate medical treatment should be sought. This medicine should be kept out of the reach of children and should remain sealed until just before use.
Not everyone experiences these, and they can vary from person to person.
This medicine may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the effectiveness of the medicine.
This medicine is a white or off-white, oval tablet with a biconvex shape.
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Genuwon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.